Oncology Letters · 2017 · 23 citations · 21 references
MedicineCancer BiologyOncologyGene ExpressionMetastasisMolecular OncologyCancer BiomarkersCancer GenomicsCancer TranscriptomicsMolecular Tumor ProfilingNoncoding Rna BiologyNoncoding Rna In CancerAntisense RnasBiomarkers Of Gastric CancerCox RegressionLong Non-coding Ribonucleic AcidsLong Non-coding Rna BiomarkersLong Noncoding Rna BiomarkersLymph Node Metastasis BiomarkersLymph Node Metastasis Prognosis
In recent years, the identification of long non-coding RNAs (lncRNAs) led to the analysis of their characteristics in cancer biology. However, the expression of lncRNAs in cancer and their clinical significance remain unclear. In the present study, an investigation of lncRNAs that may be involved in the regulation of metastasis using microarray and polymerase chain reaction analyses resulted in the identification of MLLT4 antisense RNA 1 (MLLT4-AS1) as a significantly downregulated lncRNA in gastric cancer tissue compared with normal adjacent tissue (P=0.006). Furthermore, the downregulation of MLL4-AS1 was significantly associated with advanced Tumor-Node-Metastasis stage (P=0.007) and lymph node metastasis (P=0.008). Cox regression analysis showed that MLLT4-AS1 expression was an independent predictor for overall survival (hazard ratio, 13.136; 95% confidence interval, 5.065-34.068; P<0.001). These data suggest that the decreased expression of MLLT4-AS1 is a potential biomarker and a predictor of a poor prognosis for gastric cancer.
21
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
John L. Rinn, Michael A. Kertesz, Jordon K. Wang et al. · Cell · 2007 · 4.3K citations · Full text
Farin Kamangar, Graça M. Dores, William F. Anderson · Journal of Clinical Oncology · 2006 · 3.5K citations